CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLSD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	20 : 05	GlobeNewswire Inc.	Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/11	05 : 31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/10	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/09	05 : 15	GlobeNewswire Inc.	Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference	NASDAQ:CLSD	Clearside Biomedical Inc
2024/04/30	20 : 05	GlobeNewswire Inc.	Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024	NASDAQ:CLSD	Clearside Biomedical Inc
2024/04/16	20 : 05	GlobeNewswire Inc.	Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors	NASDAQ:CLSD	Clearside Biomedical Inc
2024/04/02	20 : 05	GlobeNewswire Inc.	Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:CLSD	Clearside Biomedical Inc
2024/03/18	20 : 05	GlobeNewswire Inc.	Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer	NASDAQ:CLSD	Clearside Biomedical Inc
2024/03/13	05 : 05	GlobeNewswire Inc.	Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/29	21 : 05	GlobeNewswire Inc.	Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/09	07 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/09	06 : 52	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/07	22 : 00	GlobeNewswire Inc.	Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/02	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2024/01/20	08 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLSD	Clearside Biomedical Inc
2024/01/20	05 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLSD	Clearside Biomedical Inc
2023/12/29	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2023/12/14	21 : 05	GlobeNewswire Inc.	Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/14	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/14	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/14	06 : 05	GlobeNewswire Inc.	Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/08	21 : 05	GlobeNewswire Inc.	Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/08	06 : 20	GlobeNewswire Inc.	Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/04	01 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/04	01 : 00	GlobeNewswire Inc.	BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/02	20 : 05	GlobeNewswire Inc.	Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/01	20 : 05	GlobeNewswire Inc.	Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD	NASDAQ:CLSD	Clearside Biomedical Inc
2023/10/31	20 : 05	GlobeNewswire Inc.	Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023	NASDAQ:CLSD	Clearside Biomedical Inc
2023/10/16	20 : 05	GlobeNewswire Inc.	Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting	NASDAQ:CLSD	Clearside Biomedical Inc